432529-50-5

Basic information

• Product Name: 4-(4-fluorobenzyloxy)benzaldehyde oxime
• Synonyms: 4-(4-fluorobenzyloxy)benzaldehyde oxime
• CAS NO: 432529-50-5
• Molecular Weight: 245.253
• Mol File: 432529-50-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 4-(4-fluorobenzyloxy)benzaldehyde oxime(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(4-fluorobenzyloxy)benzaldehyde oxime(432529-50-5)
• EPA Substance Registry System: 4-(4-fluorobenzyloxy)benzaldehyde oxime(432529-50-5)

Safety Data

• Hazardous Substances Data: 432529-50-5(Hazardous Substances Data)

Upstream product

• 123-08-0 4-hydroxy-benzaldehyde 
• 459-46-1 4-Fluorobenzyl bromide 
• 56442-17-2 4-((4-fluorobenzyl)oxy)benzaldehyde 

Downstream Products

• 1399258-99-1 N-[4-(4-fluoro-benzyloxy)-benzyl]-hydroxylamine 
• 1399259-05-2 (4aS,4bR,5S,6aS,6bR,9aS,10aS,10bS,12S)-4b,12-difluoro-8-[4-(4-fluoro-benzyloxy)-benzyl]-5-hydroxy-6b-(2-hydroxy-acetyl)-4a,6a-dimethyl-4a,4b,5,6,6a,6b,8,9,9a,10,10a,10b,11,12-tetradecahydro-7-oxa-8-aza-pentaleno[2,1-a]phenanthren-2-one 
• 1399259-07-4 (4aS,4bR,5S,6aS,6bR,9aS,10aS,10bS,12S)-4b,12-difluoro-8-[4-(4-fluoro-benzyloxy)-benzyl]-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,8,9,9a,10,10a,10b,11,12-tetradecahydro-7-oxa-8-aza-pentaleno[2,1-a]phenanthrene-6b-carboxylic acid 
• 1399259-09-6 (4aS,4bR,5S,6aS,6bR,9aS,10aS,10bS,12S)-8-((4-fluoro-benzyloxy)-benzyl)-4b,12-difluoro-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,8,9,9a,10,10a,10b,11,12-tetradecahydro-7-oxa-8-aza-pentaleno[2,1-a]phenanthrene-6b-carbothioic acid S-fluoromethyl ester 

Relevant articles and documents

SUBSTITUTED ISOXAZOLE AMINE COMPOUNDS AS INHIBITORS OF SCD1

The invention is concerned with a compound of formula (I) wherein R1 to R3 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.

ISOXAZOLIDINE DERIVATIVES

The present invention relates to novel anti-inflammatory and antiallergic compounds of the glucocorticosteroid series, methods of preparing such compounds, pharmaceutical compositions comprisingthem, combinations and therapeutic uses thereof. More particularly, the invention relates to glucocorticosteroids that are derivatives of isoxazolidine.